Article
Stay Denied; Expedited Appeal Granted In Namenda Product Hopping Suit
Following the S.D.N.Y.’s award to the New York State Attorney General of an injunction requiring Actavis to continue distributing the immediate-release tablet version of its dementia drug, Namenda (which we analyzed previously), the Second Circuit Court of Appeals has denied
Patterson Belknap Webb & Tyler LLP
